Prestige Brand
Yahoo Finance • last month
Oppenheimer lists 5 retail stocks investors should own for 2025
Investing.com -- Oppenheimer in a note dated Wednesday flagged five key retail stocks that they believe investors should seriously consider as part of their portfolios heading into 2025. The stocks identified—Church&Dwight Co (NYSE:CHD),... Full story
Yahoo Finance • 10 months ago
Prestige Consumer Healthcare Inc. (PBH) Reports Modest Revenue and EPS Growth in Q3 Fiscal 2024
Revenue: Q3 revenue increased by 2.6% year-over-year to $282.7 million. Net Income: Q3 net income rose to $53.0 million, a 2.2% increase from the previous year. Earnings Per Share (EPS): Diluted EPS for Q3 was $1.06, up from $1.04 year-ove... Full story
Yahoo Finance • 10 months ago
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
Prestige Consumer Healthcare Inc. Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior Year Diluted EPS of $1.06 in Q3, Up 2.2% Versus Prior Year Reduced Leverage Ratio to 2.9x at Quarter End Raising Full-Year Fiscal 2024 Earnings Outloo... Full story
Yahoo Finance • 11 months ago
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
Prestige Consumer Healthcare Inc. Americaine® 20% Benzocaine Topical Anesthetic Spray Americaine® 20% Benzocaine Topical Anesthetic Spray TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Hea... Full story
Yahoo Finance • 11 months ago
Kenvue: A High-Quality Consumer Health Company on Sale
In May, Kenvue Inc. (NYSE:KVUE) successfully concluded its separation from Johnson & Johnson (NYSE:JNJ); however, its stock has experienced a decline about 25% since the completion of this process, likely driven by Investors nervousness ab... Full story
Yahoo Finance • last year
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
Revenue of $286.3 Million in Q2, Ahead of OutlookDiluted EPS of $1.07 in Q2, Up Over 5% Versus Prior YearReduced Leverage Ratio to 3.0x at Quarter EndReaffirming Full-Year Fiscal 2024 Revenue, Earnings, and Cash Flow Outlook TARRYTOWN, N.... Full story
Yahoo Finance • last year
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the ma... Full story
Yahoo Finance • last year
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET. All inte... Full story
Yahoo Finance • last year
Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results
TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first quarter earnings release on Thursday, August 3, 2023 before the opening of the marke... Full story
Yahoo Finance • last year
Prestige Consumer Healthcare Publishes Inaugural Sustainability Report
TARRYTOWN, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced the release of its inaugural Environmental, Social, and Corporate Governance (ESG) Sustainabil... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023
Revenue of $285.9 Million in Q4 and $1,127.7 Million in Fiscal 2023Organic Revenue Grew 8.0% in Q4 and 3.5% in Fiscal 2023Achieved Leverage Ratio of 3.3x at Year End; Revising Long-term Leverage Target to Less than 3.0xInitial Full-Year Fi... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 18, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 fourth quarter and year-end earnings release on Thursday, May 4, 2023 before the opening... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. Reports Third Quarter Results
Revenue of $275.5 Million in Q3 fiscal 2023 increased 0.4% versus Prior Year and 1.8% excluding CurrencyDiluted EPS of $1.04 for Q3 fiscal 2023 increased 5.1% versus Prior YearReduced leverage ratio to 3.5x in Q3, enabled by strong profita... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. to Present at the 2023 ICR Conference
TARRYTOWN, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in the 2023 ICR Conference and is scheduled to host a fireside chat Tuesday, January 10, 2023 at 2:3... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results
TARRYTOWN, N.Y., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 third quarter earnings release on Thursday, February 2, 2023 before the opening of the mar... Full story
Yahoo Finance • 2 years ago
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued
Does the November share price for Prestige Consumer Healthcare Inc. (NYSE:PBH) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's val... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023
Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding CurrencyDiluted EPS of $1.02 for Q2, ahead of expectationsReduced Debt by $35 million in Q2 and Achieved Leverage Ratio of 3.7xReaffirmi... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference
TARRYTOWN, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) will present at the 2022 Barclays Global Consumer Staples Conference on Thursday, September 8, 2022 at 12:45 p.m. ET. All interested parties... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
Revenue of $277.1 Million in Q1 fiscal 2023 increased 2.9% versus Prior YearDiluted EPS of $1.09 for Q1, ahead of expectationsNet Cash Provided by Operating Activities of $58.2 Million and Non-GAAP Free Cash Flow of $57.2 MillionReaffirmin... Full story
Yahoo Finance • 2 years ago
Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results
TARRYTOWN, N.Y., July 11, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 first quarter earnings release on Thursday, August 4, 2022 before the opening of the marke... Full story
